Circadian Oscillations of Protein-Coding and Regulatory RNAs in a Highly Dynamic Mammalian Liver Epigenome  by Vollmers, Christopher et al.
Cell Metabolism
ResourceCircadian Oscillations of Protein-Coding
and Regulatory RNAs in a Highly Dynamic
Mammalian Liver Epigenome
Christopher Vollmers,1,5 Robert J. Schmitz,2,5 Jason Nathanson,3 Gene Yeo,3 Joseph R. Ecker,2,4,* and
Satchidananda Panda1,*
1Regulatory Biology Laboratory
2Genomic Analysis Laboratory
Salk Institute for Biological Studies, La Jolla, CA, 92037, USA
3Department of Cellular and Molecular Medicine, Stem Cell Program, Institute for Genomic Medicine, University of California, San Diego,
La Jolla, CA 92037, USA
4Howard Hughes Medical Institute
5These authors contributed equally to this work
*Correspondence: ecker@salk.edu (J.R.E.), satchin@salk.edu (S.P.)
http://dx.doi.org/10.1016/j.cmet.2012.11.004SUMMARY
In the mouse liver, circadian transcriptional rhythms
are necessary for metabolic homeostasis. Whether
dynamic epigenomic modifications are associated
with transcript oscillations has not been systemati-
cally investigated. We found that several antisense
RNA, lincRNA, and microRNA transcripts also
showed circadian oscillations in adult mouse livers.
Robust transcript oscillations often correlated with
rhythmic histone modifications in promoters, gene
bodies, or enhancers, although promoter DNAmeth-
ylation levels were relatively stable. Such integrative
analyses identified oscillating expression of an anti-
sense transcript (asPer2) to the gene encoding the
circadian oscillator component Per2. Robust tran-
script oscillations often accompanied rhythms in
multiple histone modifications and recruitment of
multiple chromatin-associated clock components.
Coupling of cycling histone modifications with
nearby oscillating transcripts thus established a
temporal relationship between enhancers, genes,
and transcripts on a genome-wide scale in a mam-
malian liver. The results offer a framework for under-
standing the dynamics of metabolism, circadian
clock, and chromatin modifications involved in
metabolic homeostasis.
INTRODUCTION
To adapt to changing energy intake and demand throughout the
day, a large number of hepatic protein-coding transcripts show
diurnal rhythms driven by a cell-autonomous circadian oscillator,
metabolic sensors responding to feeding-fasting cycle, and
rhythmic neuroendocrine signals (Hughes et al., 2009; Vollmers
et al., 2009; Yang et al., 2006). Mice lacking circadian clock
components or those with ad lib access to high-fat diet exhibitCell Mdampened rhythms and succumb to metabolic diseases (Asher
and Schibler, 2011). Conversely, an imposed feeding-fasting
cycle improves these rhythms and prevents diet-induced
obesity (Hatori et al., 2012), thus establishing the significance
of rhythmic transcription for metabolic homeostasis.
The circadian oscillator is based on a transcription feedback
loop in which the redox-sensing BMAL1/CLOCK heterodimer
drives transcription of Cry, Per, Ror, and Rev-erb genes. The
CRY/PER complex inhibits BMAL1/CLOCK transcriptional
activity, thus producing intrinsic oscillations in their own tran-
scripts. REV-ERBs and RORs act as repressors and activators
of Bmal1 and other clock genes, thus driving their transcriptional
oscillations (Cho et al., 2012; reviewed in Reddy and O’Neill,
2010). These core oscillator components and their immediate
targets (e.g., Dbp, Bhlhb2, Bhlhb41, Pgc1a, Pparg, Essr, Tef,
Hlf, and Nfil3) drive oscillating transcription of downstream
genes (Dibner et al., 2010). Independent of the circadian oscil-
lator, the feeding-fasting cycle can also drive oscillations by
signaling throughmetabolic regulators, including CREB, SREBP,
ATF, and FoxO (Vollmers et al., 2009).
The circadian system imparts reciprocal regulation with meta-
bolism. Cellular redox state, NAD, AMP/ATP ratio, biosynthesis
of heme, and several ligands for nuclear hormone receptors
show diurnal rhythms (Asher and Schibler, 2011; Bass and Taka-
hashi, 2010) that, in turn, reinforce the oscillating activities of
several transcription factors. Additionally, metabolic products
of S-adenosyl-methionine (SAM) and coenzymes involved in
histone and DNAmethylation show diurnal rhythms. The methyl-
ation-dependent SAM metabolite S-adenosyl-homocysteine
and the methylation-independent metabolite polyamines show
oscillations in hepatocytes. Similar rhythms are observed in
hepatic Coenzyme A, riboflavin, and TCA cycle intermediates
involved in synthesis of acetyl-coA, FAD, and a-ketoglutarate,
respectively (Atwood et al., 2011; Eckel-Mahan et al., 2012;
Hatori et al., 2012).
There is increasing evidence that dynamic changes in histone
modifications at circadian oscillator controlled loci contribute to
oscillating transcription (Masri and Sassone-Corsi, 2010).
BMAL1/CLOCK and PER/CRY complexes interact with several
histone modifiers, including WDR5, EZH, JARID1a, HDAC, andetabolism 16, 833–845, December 5, 2012 ª2012 Elsevier Inc. 833
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at the promoters of Per1, Per2, and Dbp (Brown et al., 2005;
DiTacchio et al., 2011; Etchegaray et al., 2006; Katada and Sas-
sone-Corsi, 2010; Naruse et al., 2004; Ripperger and Schibler,
2006), whereas REV-ERB and CRY interact with HDACs to drive
circadian oscillations in H3ac at Bmal1 and Per promoters,
respectively (Alenghat et al., 2008; Curtis et al., 2004; Feng
et al., 2011). Genetic perturbations of these histone-modifying
agents or of their interactions affect circadian transcriptional
rhythms and disrupt metabolic homeostasis (Alenghat et al.,
2008; Katada and Sassone-Corsi, 2010). In addition, CREB
and FOXO3 also interact with p300/CBP (Kwok et al., 1994;
van der Heide and Smidt, 2005). The p300/CBP complex carries
out histone acetylation, including H3K27 acetylation at both
promoters and enhancers (Ramos et al., 2010; Visel et al., 2009).
Although dynamic circadian oscillations of histone modifica-
tions at a few genes have been examined, such regulation likely
extends to a large part of the genome. Whole-genome analyses
of REV-ERB, HDAC3 occupancy, and H3K9ac showed high
H3K9ac at thousands of loci during morning and reduced
H3K9ac at the same loci in the evening (Feng et al., 2011). Simi-
larly, BMAL1 cistrome analyses identified its binding at hundreds
of oscillating transcripts (Rey et al., 2011). These genome-wide
studies hinted at global diurnal rhythms in the hepatic epige-
nome. Furthermore, both BMAL1 and REV-ERB binding at
hundreds of sites outside the well-characterized promoters of
protein-coding genes (Cho et al., 2012; Feng et al., 2011; Rey
et al., 2011) implied that these sites might specify enhancers or
promoters of nonprotein coding novel transcripts.
In this genome-wide integrative study, we investigated the
association between the dynamic hepatic transcriptome and
its epigenome in adult mouse livers over the course of 24 hr.
Using a deep-sequencing approach, we determined temporal
genome-wide changes in the levels of strand-specific RNA,
microRNAs (miRNAs), the histone modifications H3K4me3,
H3K9ac, H3K4me1, H3K27ac, and H3K36me3, and cytosine
DNA methylation. We discovered circadian oscillation of
protein-coding messenger RNAs (mRNAs), as well as a number
of overlapping RNA, lincRNA, and miRNA transcripts. Although
promoter DNA methylation showed no significant changes
associated with transcript oscillations, oscillations in histone
modifications were pervasive and temporally correlated with
the transcript oscillations at proximal loci. Beyond gene bodies
and promoters, oscillations in histone modifications were also
detected at enhancers, allowing establishment of functional
transcript-enhancer associations.
RESULTS
Deep Sequencing Methods Identified Circadian
Changes in the Liver Transcriptome and Epigenome
Mice held under constant condition were sacrificed every 3 hr,
and their livers were collected. Strand-specific poly(A)+ RNA-
sequencing (RNA-seq) and chromatin immunoprecipitation
sequencing (ChIP-seq) on H3K4me3, H3K27ac, H3K36me3,
H3K4me1, and H3K9ac throughout a 24 hr day (circadian time
0 [CT0]–CT24) (Figures S1A–S1C available online) were per-
formed. These five histone modifications define, alone or in a
combinatorial manner, major chromatin domains at promoters834 Cell Metabolism 16, 833–845, December 5, 2012 ª2012 Elsevier(H3K4me3, H3K27ac, H3K4me1, and H3K9ac), gene bodies
(H3K36me3), and enhancers (H3K27ac and H3K4me1). Addi-
tionally, the DNA methylomes of the liver at two opposing time
points (CT9 and CT21) were determined by whole-genome
bisulfite sequencing (MethylC-seq) (Lister et al., 2008).
To test sufficiency of sequencing depth for detection of circa-
dian oscillations, we visualized mapped sequence tags for
two known oscillating genes (Figures S2A and S2B): BMAL1/
CLOCK-driven xenobiotic metabolism regulator Dbp and circa-
dian oscillator- and SREBP-driven Elovl3 (Anzulovich et al.,
2006). In addition to confirming oscillations in H3K4me3 and
H3K9ac modifications at specific sites in the promoter and the
first intron of Dbp (Ripperger and Schibler, 2006), we also found
synchronous oscillations in H3K4me3 and H3K27ac at the
promoter and H3K36me3 in the gene body, peaking in the late
afternoon (CT9) when transcript levels also peaked (Figure S2A).
In contrast, promoter H3K4me1 levels peaked when transcript
levels were at their lowest. The Elovl3 locus also showed oscilla-
tions in transcript and in histone modifications (Figure S2B), but
the phase of oscillations was distinct from Dbp. In summary,
these results demonstrate the robustness of these assays in
detecting oscillations.
Strand-Specific RNA-Seq Uncovers a Wide Range of
Oscillating RNA Species in Their Genomic Context
A total of 14,492 active genes were identified, many of which
were undetectable by high-density array (HDA)-based methods
(Hughes et al., 2009) (Figure S3A). Transcript levels of active
genes correlated with liver RNA-seq data set from an indepen-
dent laboratory (Figure S3B) (Mortazavi et al., 2008). A set of
1,262 (9% of expressed) oscillating transcripts (Figures 1A and
1B and Table S1) were identified (COSOPT [Straume, 2004],
p < 0.02, 20 < period (t) < 28 hr) with at least 2-fold peak to trough
ratio. Of the 1,262 oscillating transcripts, 1,160 were protein
coding, including well-characterized genes implicated in meta-
bolic regulation such as Arntl (Bmal1), Insig2, Fbxo21, Dbp,
Thrsp, Per2, Rorc, Cry1, and Elovl3 (Figures 1A and 1B) (Hughes
et al., 2009; Panda et al., 2002; Ueda et al., 2002). Four hundred
forty-six protein-coding transcripts identified by RNA-seq were
also scored oscillating and shared similar phases of expression
in the earlier HDA-based detection (R2 = 0.89) (Figure S3C and
Table S2), thus establishing the RNA-seq approach as repro-
ducible. Additionally, 135 oscillating mRNAs and 102 oscillating
non-protein-coding transcripts identified by RNA-seq were
either undetectable or not represented in the HDA platform (Fig-
ure S3D and Table S3). The times of peak levels of the 1,262
oscillating transcripts were distributed throughout 24 hr, with
moderate prevalence in the subjective morning (CT21–CT3:
301 transcripts or 24%) and subjective evening (CT9–CT15;
373 transcripts or 37.5%) (Figure 1C) coinciding with the end
of nocturnal feeding and the diurnal fasting period in mice,
respectively. Overall, the 1,262 oscillating transcripts showed
median expression that was comparable to all active genes
and peak to trough expression changed mostly under 10-fold
(Figures S3E and S3F).
The strand-specific RNA-seq readout enabled identification
of oscillating transcripts in their genomic context. Nearly 25%
(336 genes) of loci with oscillating transcripts were in close prox-
imity (<500 bp or fewer than three nucleosomes) or overlappedInc.
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Figure 1. Strand-Specific and Small RNA Sequencing Identified Oscillating Sense RNA, Antisense RNA, and miRNA Transcripts in the
Mouse Liver
(A and B) Oscillating transcripts (1,262) are shown in a heatmap (A) or polar plot (B). In polar plot, peak phase is shown along the radial coordinate, the distance to
the center of the circle shows the amplitude of transcript oscillation. Average transcript levels over 24 hr are proportional to the radius of the marker. Examples of
known oscillating transcripts are shown in red.
(C) Frequency plot percentage of oscillating transcripts with peak phase of expression binned in 3 hr over 24 hr.
(D) Klf13/AC148977.1 locus shows oscillations in both sense and antisense transcripts. RNA levels on the plus (red) and minus (green) strands are in 150 bp bins
and visualized for each time point.
(E) Antisense transcript AC148977.1 (red) and Klf13 (green) are plotted.
(F) Fifty-four oscillating miRNAs are shown in a heatmap.
(G) Normalized tag counts of example miRNAs show circadian oscillations.
See also Figures S1–S5 and Tables S1, S2, and S7.
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lapping pairs (22 loci out of 336, or <10%) showed oscillation of
both transcripts (Table S5 and Figure S4B), suggesting genomic
overlap does not increase probability of the pair to exhibit
circadian oscillation. For example, although the transcript for
Rev-erba (NR1D1) robustly oscillates, the transcript from its
overlapping gene pair thyroid hormone receptor alpha (Thra)
did not pass the criteria for oscillation (Figure S4B). Additionally,
36 loci with oscillating transcript levels were completely encap-Cell Msulated within other loci (Table S6), of which four showed oscil-
lating transcript (Figure S4B). An oscillating 3.8 kb lincRNA
AC148977.1 transcript and a second unannotated transcript of
3.6 kb with peak phase of oscillation in the early morning are
located inside the 47.5 kb zinc-finger transcription factor Klf13
locus, whose transcript levels also show clear oscillations with
peak expression in the evening (Figures 1D and 1E).
Transcript oscillations were not limited to protein-coding loci.
Out of 123 detected lincRNAs, 19 showed robust oscillationsetabolism 16, 833–845, December 5, 2012 ª2012 Elsevier Inc. 835
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Figure 2. Temporal Changes in Histone Modifications at Oscillating Loci Are Distinct from Differences in Histone Modification Signatures
at Expressed and Silent Loci
(A) Scatter plot of transcript levels (x axis) and the indicated epigenomic feature (y axis). RNA, histone modification, and DNA methylation at promoter or gene
body regions of 14,492 expressed genes were grouped in bins of 100 and median normalized. H3K4me3, H3K4me1, H3K9ac, and H3K27ac are shown as reads
per promoters (RPP), while H3K36me3 is shown as reads per kilobase of gene body (RPK). DNAmethylation is shown as the ratio of methylated CG to total CG in
the promoters (±4 kb).
(B) Average enrichment patterns of histone modifications and the extent of DNAmethylation is shown in the promoter areas of active versus inactive genes. The y
axis shows the extent of enrichment in reads per 150 bp bins (RPB).
(C) Average DNA methylation and histone modifications in the promoters of 700 oscillating genes at either peak (p) or trough (t) of transcript levels.
See also Figures S2 and S5 and Table S8.
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to annotated miRNAs identified 258 expressed miRNAs, includ-
ing several miRNAs expressed in the mouse liver, such as
miR-33, miR-122, miR-103, miR-107, miR-221, and the Let-7
family of miRNAs (Fornari et al., 2008; Frost and Olson, 2011;
Jopling et al., 2005; Najafi-Shoushtari et al., 2010; Rayner
et al., 2010; Trajkovski et al., 2011). In addition to miR-122, the
only miRNA previously shown to have circadian oscillations in
the liver (Gatfield et al., 2009), we identified circadian oscillations
in 53 miRNAs (Figures 1F and 1G and Table S7). Among the
oscillating miRNAs, Let-7, miR-33, miR-103, and miR-122 have
already been implicated in liver function (Frost and Olson,
2011; Gatfield et al., 2009; Rayner et al., 2010; Trajkovski et al.,
2011) and thereby add an additional mode of circadian regula-
tion to physiology and metabolism.
DNA Methylation Does Not Display Robust Changes
at Transcriptionally Oscillating Loci
Oscillation in DNA methylation is associated with subcircadian
(<24 hr) transcriptional oscillations in cultured cells (Kangaspe-836 Cell Metabolism 16, 833–845, December 5, 2012 ª2012 Elsevierska et al., 2008; Me´tivier et al., 2008). We tested whether hepatic
DNA methylation levels change between late afternoon (CT9)
and late night (CT21), when two large clusters of oscillating
transcripts (704 loci) approach their peak levels (Figure 1C).
DNA methylation in the mouse liver occurred almost exclu-
sively in a CG context (99.99%). Across all active loci, promoter
methylation was inversely associated with transcript levels (Fig-
ure 2), except for highly expressed loci (18% of all active loci,
FPKM > 106), which contained slightly higher promoter CG
methylation (Figure 2A). A comparison of promoter DNA meth-
ylation levels in the oscillating genes peaking at CT9 or CT21
and even those with >10-fold change between peak and trough
level of RNA revealed no differences (<1%, Table S8) in
promoter DNA methylation levels between peak and trough
times of transcription (Figure 2C and Figure S5), although
histone modifications showed clear differences (discussed in
the next section). A systematic analysis to detect time-depen-
dent differentially methylated regions (DMR) identified only 18
DMRs, 16 of which fell into genes, none of which showed clear
oscillating transcription (Table S9). In summary, circadianInc.
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amplitude.
Widespread Changes in Patterns of Histone
Modifications along a Circadian Timescale
Thefive investigated histonemodificationsH3K4me1,H3K4me3,
H3K9ac, H3K27ac, and H3K36me3 were enriched in actively
transcribed genes (Figure 2B) correlated (R2 = 0.61–0.74) with
transcript levels (Figure 2A). Promoter H3K4me1 and gene-
body H3K36me3 reached a plateau in highly expressed loci
(Figure 2A), thus implying circadian changes in these histone
modifications may be modest. Unlike the wide dynamic range
of transcript levels spanning several orders of magnitude, the
dynamic range of histone modifications spanned only up to one
order of magnitude due to the finite number of sites accessible
for histone modification.
All five histone modifications tested showed clear changes
between peak and trough levels of 704 oscillating transcripts
(Figure 2C) that reached maximum expression at CT9 and
CT21. Normalized average levels of H3K4me3, H3K9ac,
H3K27ac, and H3K36me3 were higher at the peak time of
transcription and were lower at the trough time of transcription
in 704 oscillating loci (Figure 2C) but did not approach the
chromatin signature of inactive loci. We systematically examined
circadian oscillations in the levels of the most dynamic modifi-
cations, H3K4me3 and H3K27ac.
Oscillating H3K4me3 and Transcript Levels Define
Oscillating Transcript-Promoter Pairs
We identified robustly oscillating H3K4me3 levels at 826
promoters (transcription start site [TSS] ± 4 kb, COSOPT p <
0.02, 20 hr < t < 28 hr, peak to trough fold change [FC] R
1.5) (Figures 3A and 3B and Table S10), of which 154 were
associated with genes with no detectable transcript levels at
two or more of the eight time points. These undetectable
transcripts represent largely uncharacterized transcripts or
poly(A) transcripts, which were underrepresented in the
poly(A)+ pool selected for transcript sequencing. Of the remain-
ing 662 oscillating H3K4me3 promoter peaks, 163 were asso-
ciated with robust transcript oscillations (Figure 3C and Table
S11) forming oscillating transcript-promoter pairs. The majority
of promoters with oscillating H3K4me3 peaks were associated
with oscillating transcripts, which did not meet at least one
of the three criteria for robust oscillation (Figure 3D). The
163 oscillating transcript-promoter pairs were enriched for
circadian oscillator components and key regulators of liver
metabolism, including Bmal1, Cry1, Per1, Per2, Per3, Rorc,
Foxo3, Gadd45a, Fgfr2, Mthfr, Cdkn1a, Rev-erba, Dbp, Tef,
and Nfil3.
In these 163 loci, temporal changes in promoter H3K4me3
and other histone modifications were closely coupled to oscilla-
tions in transcript levels (Figures 3E–3I). Gene body H3K36me3,
which was measured at only four time points, also showed
clear, albeit noisy oscillations, which peaked at roughly the
same time as associated transcript levels. Promoter H3K4me1,
which likely results from demethylation of H3K4me3 during
poised basal period of transcription, showed oscillations with
its peak phase opposite to that of associated transcript levels.
Overall, these data reveal genomic loci that undergo highlyCell Mdynamic and reversible changes to their local chromatin environ-
ments on a circadian timescale.
Oscillating H3K4me3 Outside of Annotated Promoters
Identified Transcripts, Including asPer2
In addition to rhythmic H3K4me3 at bona fide promoters,
267 intragenic and 219 intergenic H3K4me3 peaks oscillated
(Tables S12, S13, and S14 and Figures 4A and 4B). The majority
of these nonpromoter peaks were coenriched for H3K9ac or
H3K27ac and likely mark alternative TSS in gene bodies or
TSS of transcripts. Of the 267 oscillating peaks in gene bodies,
47 are located in 44 oscillating genes (Table S12) including
Psen2, Camk1d, Rarb, Syne1, Hsd3b7, and Ccnf (Figure 4B).
The peak phases of gene body H3K4me3 levels was synchro-
nous with the corresponding rhythmic transcript, except at two
loci:AC156021.1 and Per2. Both peaks are oscillating antiphasic
to the respective genes they are located within and both peaks
are accompanied with oscillating levels of antisense RNA. The
intragenic H3K4me3 levels peak at CT6 and are temporally
correlated with an antisense transcript of Per2 (asPer2) (Fig-
ure 4C). The asPer2 RNA starts at the H3K4me3 peak 16.5 kb
downstream of Per2 TSS and extends for 10.2 kb into the 50
untranslated region of the sense transcript. The asPer2 expres-
sion reaches its maximum at CT3, 12 hr after Per2 transcript
peaks (Figure 4D). Antisense transcript of Neurospora clock
component frq has been shown to modulate the intrinsic oscilla-
tion and light-induced change in frq transcript (Kramer et al.,
2003). Accordingly, asPer2 transcription might add another level
of control to Per2 transcription.
Most of the 219 oscillating intergenic H3K4me3 peaks are
relatively low in average H3K4me3 enrichment (promoter,
108.1; gene body, 47.7; intergenic, 25.2 reads per peak [RPP])
and likely mark TSS of transcripts expressed at low levels.
Indeed, 179 were associated with detectable (more than ten
reads in adjacent ± 10 kb) RNA levels (Table S14 and Figure 4E).
In summary, the combination of nonpromoter H3K4me3 rhythm
with strand-specific RNA-seq revealed rhythmic transcripts.
Oscillating H3K27ac Defines Oscillating Enhancers
The role of enhancers in circadian gene expression has been
limited. We identified 25,244 H3K27ac+/H3K4me1+/H3K4me3
peaks, which we defined as enhancers (Figures 5A and 5B)
(Guenther et al., 2007; Roh et al., 2006). Since H3K4me1 marks
enhancers and changes in H3K27ac levels define enhancer
activity (Creyghton et al., 2010), H3K27ac levels at these regions
were tested for oscillations. Unlike the promoter histone modifi-
cations spatially linked to TSS, H3K27ac only defined spatially
unrestrained active enhancer sites. Therefore, we used more
stringent criteria than used for H3K4me3 (COSOPT p < 0.01,
20 < t < 28 hr, peak to trough ratio > 2) and found 1,025 oscil-
lating enhancers (Table S15 and Figure 5C). Within 200 kb
(±100 kb) flanking each oscillating enhancer, accounting for
a sample space of 205Mb or <7%of the genome, 283 oscillating
enhancer-transcript pairs (27.6% of oscillating enhancers;
Figures 5D–5F and S6A and Table S16) were identified.
Granger’s causality analysis found a significant correlation
between the times of peak H3K27ac levels at enhancers and
associated transcript oscillations (p < 2 3 1038). In addition to
enhancers, oscillating H3K27Ac was also defined at promotersetabolism 16, 833–845, December 5, 2012 ª2012 Elsevier Inc. 837
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Figure 3. Oscillating H3K4me3 Identified Highly Dynamic Histone Modifications at Promoters
(A) Schematics for identification of oscillating H3K4me3 peaks.
(B) Heatmap rendering of oscillating promoter H3K4me3 levels at 826 loci.
(C) Venn diagram of overlap between oscillating transcripts and oscillating H3K4me3 at their promoters.
(D) The absolute changes of transcript (dFPKM) and H3K4me3 (dRPP) levels of 1,262 oscillating genes are shown in a scatter plot in red. One hundred sixty-three
loci with oscillating H3K4me3 levels are shown in black.
(E) Scatter plot of the peak phase of transcript (x axis) and H3K4me3 (y axis) at 163 oscillating transcript-H3K4me3 pairs.
(F) Difference in peak phase between transcript and H3K4me3 levels.
(G) Histone modification levels in 163 oscillating loci are normalized relative to transcript peak time.
(H) Heatmap representation of the levels of transcript, H3K4me3, H3K9ac, H3K27ac, H3K36me3 (gene body), and H3K4me1 levels in 163 oscillating transcript-
promoter H3K4me3 pairs.
(I) Examples of temporally correlated oscillating promoter H3K4me3 levels and transcript. Gene symbols, normalized histone modification levels and transcript
levels are shown.
See also Figures S1, S2, and S5 and Tables S10–S12.
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H3K27Ac, at both enhancers and promoters, along with pro-
moter H3K4me3 oscillations act synergistically to boost tran-
script oscillations (Figures 5G–5I).
Some of the oscillating enhancers highlight nodes for circa-
dian control of metabolic regulators. Oscillating enhancers
were mapped to Cry1, Bmal1, and Insig2 (Figures 6A and
S6B). The oscillating enhancer in the first intron of the Cry1838 Cell Metabolism 16, 833–845, December 5, 2012 ª2012 Elsevierlocus harbors a functional REV-ERB/ROR binding element
that functions in concert with oscillating BMAL1-driven tran-
scription from its canonical promoter (Rey et al., 2011; Ukai-
Tadenuma et al., 2011). Although two isoforms of cholesterol
metabolism regulator Insig2 are expressed in the liver, only
one oscillates under the regulation of REV-ERB-a to maintain
cholesterol homeostasis (Le Martelot et al., 2009). The newly
identified enhancer 42 kb upstream of the well-characterizedInc.
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Figure 4. Oscillating H3K4me3 Marks Unannotated Transcribed Loci Including asPer2
(A) Heatmap rendering of oscillating nonpromoter H3K4me3.
(B) Examples of genes with intragenic oscillating H3K4me3 and oscillating transcripts showing temporally correlated H3K4me3 and transcript rhythms
except Per2.
(C) Per2 locus shows rhythmic expression of both sense and an antisense transcript. Transcript (red/green) and H3K4me3 (black/gray) levels, binned in 150 bp
bins for both ‘‘+’’ and ‘‘–’’ strands are shown.
(D) Data for CT3 is shown magnified to highlight the asPer2 transcript. Inset histograms report oscillations in H3K4me3 levels at the potential TSS of asPer2,
asPer2 RNA levels, Per2mRNA, transcript from the sense strand in the regions corresponding to the asPer2 transcript, and rhythm in H3K4me3 at the Per2 TSS.
Corresponding regions of the locus are shown in colored boxes.
(E) Examples of oscillating intergenic H3K4me3 peaks and associated transcripts. Normalized H3K4me3 levels (black) and transcript tag counts from the plus
strand (red) or minus strand (green) in the proximal 10 kb region at eight time points through 24 hr are shown.
See also Tables S12–S14.
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Figure 5. H3K27ac Defines Oscillating Enhancers
(A) Flowchart for identification of rhythmic H3K27ac at enhancers and promoters.
(B) Histogram and heatmap rendering of various histone modifications and DNA methylation levels at enhancers.
(C) Heatmap representation of oscillating H3K27ac at enhancers and promoters.
(D and E) Heatmap representation (D) and Venn diagram (E) of 283 oscillating enhancers and proximal (within 200 kb) oscillating transcripts.
(F) Difference in peak phase between RNA and enhancer H3K27ac is shown as a histogram. H3K27ac levels preceded RNA levels.
(G) Synchronous histone modification rhythms correlate with improved amplitude of transcript oscillations. Average (+SD) peak:trough ratio (amplitude) of
oscillating transcripts with oscillating enhancer H3K27ac, promoter H3K27ac, promoter H3K4me3, or combinations of histone modification rhythms are shown.
The number of transcripts that meet these criteria is shown below.
(H and I) Gene names of 26 loci (H) and example loci (I) with robust oscillations in RNA, promoter H3K4me3, promoter H3K27ac, and enhancer H3K27ac.
See also Figures S6 and S7 and Tables S15, S16, S19, and S20.
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transcript (Figure 6B) and also harbors a REV-ERB/ROR
element.
Oscillating transcript levels of several genes (e.g., Bhmt,
Dnmt3b, Ndrg1, Fads2, Gadd45a, Asap2, and Fm02) temporally
correlated with multiple oscillating proximal enhancers (Fig-
ure S6A). Conversely, single enhancers alsomapped in the prox-
imity of multiple genes with synchronously oscillating transcripts
(Figures 6C and 6D). H3K27ac levels in an enhancer adjacent to
Abcg5, Abcg8, and Lrprrc genes were temporally correlated to
their transcript levels (Figure 6C). Both Abcg5, and Abcg8
encode two half-transporters for excretion of bile acid (Berge
et al., 2000). Coordinated circadian oscillation of the transcripts840 Cell Metabolism 16, 833–845, December 5, 2012 ª2012 Elsevierof Abcg5, Abcg8, and Lrpprc, master regulator of mitochondrial
mRNA synthesis (Ruzzenente et al., 2012), likely ensures co-
ordinated production and efflux of bile acids from hepatocytes
and robust mitochondrial protein synthesis to protect against
potential bile acid toxicity (Palmeira and Rolo, 2004). Similarly,
another circadian enhancer in chromosome 4 peaks at CT10
with the transcripts of Nol9, Klhl21, and Zbtb48 shortly after
(Figure 6D). Although the functions of these three genes are yet
to be characterized, they all encode nuclear proteins involved
in transcriptional regulation. The arrangement of genes at
these two different enhancers is conserved in the human
genome, thus emphasizing a physiological need for their corre-
lated expression.Inc.
A B
C D
Figure 6. Enhancer H3K27ac Oscillation Temporally Correlates with Transcript Oscillation from Proximal Gene or Cluster of Genes
(A and B) Transcript (red/green) and H3K27ac (blue/light blue) read density are illustrated at Cry1 (A) and Insig2 (B) loci at eight time points (H3K4me3 and
H3K4me1 read density is given as a reference in the bottom panel, and H3K4me3 is shown as insets at each time points). Enhancers are indicated as blue bars
and arrows indicate promoters of target genes.
(C and D) Single enhancers drive transcription of multiple proximal genes. Gene models and peak phase of oscillating transcripts are shown on top. Blue
horizontal bars denote enhancer regions marked by oscillating H3K27ac and absence of H3K4me3.
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Integration of RNA-seq, ChIP-seq and MethylC-seq data differ-
entiated dynamic and static parts of the epigenomic environ-
ment of oscillating genes. Although we could not conclusively
detect oscillations in DNA methylation, circadian changes at
specific nucleotide positions or in response to different meta-Cell Mbolic states cannot be ruled out. Stringent criteria used to detect
circadian transcriptome and chromatin states revealed robust
transcript oscillation linked to oscillations in different histone
modifications. Similar to histone H3K4me3, COSOPT analyses
of promoter H3K27ac identified 1,233 promoters with oscilla-
tions in H3K27ac with their phase of expression represented
throughout the day (Figure S7A). Among the 1,262 oscillatingetabolism 16, 833–845, December 5, 2012 ª2012 Elsevier Inc. 841
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H3K27ac (Table S19 and Figure S7A) with temporally correlated
oscillations in transcripts, and other histone modifications
(Figures S6A and S6B).
Throughout the genome more than 3,000 loci showed oscil-
lating levels of either H3K4me3 and/or H3K27ac with peak/
trough fold change >1.5-fold. Although we objectively monitored
temporal changes in only two ‘‘core’’ histone modifications,
several histone modifications (e.g., H2A.Z, H2BK5/12/20/
120ac, H3K4me1/2/3, H3K4/9/18/27/36ac, H3K9me1, and
H4K5/8/91ac) are coregulated (Wang et al., 2008) and are likely
to show circadian oscillations.
Although we identified 1,262 oscillating transcripts, relatively
smaller overlapping subsets accompanied robust oscillation in
histone modification rhythms. The criteria used for defining
circadian oscillation, posttranscriptional processing steps, and
synergistic interaction among histone modification rhythms or
among circadian transcription factors for robust transcript oscil-
lation might explain such insufficient overlap.
The oscillating transcripts often show modest changes
between peak and trough levels, with a median fold change <2
in several studies (Hughes et al., 2009; Panda et al., 2002;
Ueda et al., 2002; Vollmers et al., 2009). The finite number of
sites on histone tails available for modification in combination
with the limited number of histones per nucleosome dampens
the magnitude of detectable changes for oscillating histone
modifications. Since oscillating transcripts with high amplitude
(peak to trough ratio) often reproduce between independent
studies, we used stringent FC criteria for defining oscillating tran-
scriptome and chromatin modifications. For example, although
163 loci showed robust rhythms in both transcript and promoter
H3K4me3, in a scatter plot of absolute change (as opposed to
fold change) in transcript and promoter-H3K4me3 levels it is
apparent that circadian changes in transcript levels positively
correlate with the changes in promoter H3K4me3 (Figure 3D).
Therefore, at the cost of decreased reproducibility, less stringent
thresholds might reveal more oscillating transcripts, H3K4me3
peaks and transcript-promoter pairs.
We directly tested whether oscillations in promoter H3K4me3
and transcripts are uncoupled. Using reverse cutoffs (<1.5
maximum:minimum FC for RNA and oscillating promoter
H3K4me3 or <1.2-fold change for H3K4me3 and oscillating
RNA),we identifiedonly55oscillatingH3K4me3peaksassociated
with nonoscillating RNA and 22 oscillating transcripts
associated with constant H3K4me3 levels (Tables S17 and S18
andFigureS6E). Hence, for a largenumber of oscillating loci, there
exists a positive correlation between absolute changes of pro-
moter H3K4me3 and RNA. Nevertheless, discordance between
transcript and histone modification rhythms either in phase or in
levels in several loci indicates that posttranscriptional RNA pro-
cessing mechanisms likely contribute to transcript oscillations.
We also found synergistic contributions from multiple histone
modification and transcription factors oscillations on transcript
oscillations (Table S20). A subset of 26 oscillating transcripts
with detectable oscillations in promoter H3K4me3 and
H3K27ac as well enhancer H3K27ac showed elevated average
amplitude of oscillation when compared with subsets with only
one or two detectable oscillating histone modification features
(Figures 5G–5I).842 Cell Metabolism 16, 833–845, December 5, 2012 ª2012 ElsevierNext, we integrated the results from three independent circa-
dian transcription factor cistrome studies (Cho et al., 2012; Koike
et al., 2012; Rey et al., 2011). REV-ERB-a and REV-ERB-
b binding sites were found at 437 oscillating transcripts (Figures
7A and 7B), whereas BMAL1 binding sites (Rey et al., 2011) were
found at 300 oscillating transcripts (Figures 7C and 7D). Spatial
enrichment of REV-ERB or BMAL1 in these binding sites often
peaked in proximity but not overlapping with peaks of histone
modifications (Figures 7E and 7F), possibly indicating the exclu-
sion of histones through the binding of transcription factors.
Conversely, we tested whether binding of circadian transcription
regulators correlates with oscillating transcription and histone
modifications by mapping the cistromes of seven different circa-
dian regulators (Koike et al., 2012) to our data set. An average of
1.22 circadian regulator binding sites was found at each of the
14,492 expressed genes. Oscillating transcripts had significantly
more binding sites (2.08 ± 0.12, SEM) and oscillating transcript-
promoter H3K4me3 pairs had twice more (4.37 ± 0.47) clock
factors (Figure 7G).
Additionally, circadian transcription regulator binding was not
limited to promoters. Out of 2,049 BMAL1 binding sites in the
mouse genome (Rey et al., 2011), 47% (961) overlapped with
785 promoters (coenriched for H3K27ac and H3K4me3) and
30% (598 sites) overlapped with 558 enhancer regions (coen-
riched for H3K27ac and H3K4me1, but not H3K4me3). BMAL1
binding sites (Rey et al., 2011) were not only present at the
promoters of 42 out of 163 (25%) oscillating transcript-promoter
pairs, but also at the enhancers of 42 out of 283 (15%) oscillating
transcript-enhancer pairs (Tables S21 and S22 and Figures 7H–
7J). Therefore, in addition to BMAL1’s well-described role in
transcription regulation from promoter, it is also recruited to
oscillating enhancers (Figures 7H–7K).
In summary, integrative analyses of the epigenome in the
liver on the circadian timescale has expanded the ‘‘circadian
transcriptome’’ beyond protein-coding genes by revealing
a large number of noncoding and regulatory RNAs. It has
also demonstrated that oscillating transcription is associated
with circadian oscillations in histone modifications in promoters,
gene bodies, and enhancers, but not with robust rhythms in DNA
methylation. These data offer a framework to understand the ep-
igenomic basis for circadian transcription and identified the
oscillation of hundreds of mRNA, noncoding RNA, and miRNA
transcripts that exert temporal regulation of liver metabolism.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were carried out in accordance with the guidelines of
the Institutional Animal Care and Use Committee of the Salk Institute.
RNA-Seq
Ten-week-old male C57BL/6Jmice from Jackson Laboratories were entrained
to a 12:12 LD cycle for 14 days and subsequently released into constant
darkness. On day two in constant darkness, four mice were sacrificed, and
liver samples were taken every 3 hr for 24 hr. Liver samples were frozen in
liquid nitrogen and processed to a fine powderwith amortar and a pestle. Total
RNA was extracted with RNeasy columns (QIAGEN), according to the
manufacturer’s instructions. Total RNAs from all four mice were pooled and
subsequently enriched for polyadenylated RNA with the Oligotex mRNA Mini
Kit (QIAGEN). Directional RNA-seq libraries were generated according to the
standard SOLiD protocols. Time points were barcoded and sequenced onInc.
AB
C
D
E F
G
H
I J
K
Figure 7. Synergistic Role of Circadian Transcription Regulator Binding and Histone Modification Rhythms in Driving Robust Transcript
Opsillation
(A and B) Venn diagram (A) and heatmap (B) rendering of Rev-erb occupancy (blue, present; white, absent) and oscillating transcripts at 437 loci.
(C and D) Venn diagram (C) and heatmap (D) showing 300 loci with rhythmic transcripts also show rhythmic binding of BMAL1.
(E) Read density of REV-ERB-a and REV-ERB-b (light blue and purple) and H3K4me3 (black) are shown as histograms for the Per2, Insig2, and Rorc loci.
(F) Read density of BMAL1 (ZT6) and H3K4me3 (CT6) are shown as histograms for the Dbp and Nr1d1 loci. REV-ERB-a and REV-ERB-b (light blue and purple),
BMAL1 (blue), and H3K4me3 (black) are binned in 150 bp bins.
(G) Mapping the binding sites of seven different circadian regulators to expressed genes revealed propensity of their binding to genes with oscillating transcripts
and oscillating promoter H3K4me3. Average (+SEM) number of binding sites at all expressed genes (n = 14,492), rhythmic transcripts (n = 1,262), and rhythmic
transcript-promoter H3K4me3 pairs (n = 163) are shown.
(H) Mapping BMAL1 binding sites to promoter and enhancers.
(I and J) Examples of rhythmic promoter-transcript pairs (I) or rhythmic enhancer-transcript pairs (J) with BMAL1 occupancy at promoters or enhancers. Note that
at the Usp2 locus, promoter signature and BMAL1 occupancy coincides with an alternate TSS that defines Usp2.2 transcript variant.
(K) Examples of genes with oscillating transcript and temporally correlated BMAL1 in enhancers. Normalized transcript and enhancer-H3K27ac and BMAL1
levels at eight (transcript, H3K27ac) or six (BMAL1) different time points are shown.
See also Tables S21 and S22.
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Circadian Liver Transcriptome and Epigenomethe SOLiD4 sequencer. The resulting 50 bp reads were aligned to the mouse
genome (build mm9) with Bioscope (version 1.3). Transcript levels were
determined with Cufflinks (version 1.0.0) (Trapnell et al., 2010), and transcript
abundance was expressed as FPKM (fragments per kilobase of exon model
per million mapped reads) values.
ChIP-Seq
Samples were collected as for RNA-seq. Fresh liver samples were cut into
1 mm3 pieces and crosslinked in 1% formaldehyde for 15 min. Glycine
(0.125%) was added for 5min, and samples were washed twice in PBS. Cross-
linked liver pieces were homogenized with a 7 ml B-dounce. ChIP and
sequencing in Illumina GAII sequencer is described in the Supplemental
Experimental Procedures.
MethylC-Seq
DNA was extracted with a DNeasy-Tissue Kit (QIAGEN). DNA was sonicated,
ligated to adaptor and bisulphite converted (Methylcode Kit Invitrogen), and
amplified with four cycles of PCR as described previously (Lister et al.,
2009). Each sample was sequenced on a GAII sequencer (Illumina). A total
of >13 gigabases of genomic DNA were sequenced for each methylome
amounting to 4.85-fold (CT9) and 5.6-fold (CT21) coverage across the
genome. Such depth of coverage has successfully identified differentially
methylated regions in mammalian cells (Lister et al., 2011).
Small RNA Sequencing
For small RNA sequencing, mice were entrained to light:dark cycle and
released into constant darkness as described before. Whole livers from mice
were collected at 4 hr interval over 24 hr and individually homogenized in
0.5 ml RNA-bee (AMSbio, CS-501B) and then immediately diluted with an
additional 1 ml RNA-bee. RNA was extracted as described in the manufac-
turer’s protocol, and resuspended in 20 ml DEPC-H2O. Small RNA cloning
was performed as described in the Illumina Small RNADigital Gene Expression
v1.5 preparation protocol, except that we used custom oligonucleotide
adapters and primers that matched those of the Illumina TruSeq Small RNA
Sample Preparation protocol.
Data Analysis
Islands of enrichment (peak) of each chromatin modification were determined
as described in the Supplemental Experimental Procedures. Oscillations
were analyzed and scored with the pMMC-beta value as determined by the
COSOPT algorithm.
Data Availability
For visual display of the results described in this manuscript, two comple-
mentary databases have been established: a gene-centric database of over
33,000 gene models (MM9) (http://circadian-epigenomestage.salk.edu) and
an AnnoJ-based database (http://neomorph.salk.edu/circadian_epigenome/
browser.html) for interactive visualization of the data set down to single-
base resolution.
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